INTRODUCTION
Few studies have assessed the usefulness of NIV in patients with severe CAP. Nevertheless, predictors of NIV failure have been reported in different studies (1) (2) (3) (4) (5) .
Recently, Carrillo et al. noted these risk factors for NIV failure: radiographic worsening infiltration 24 hours after admission, maximum sepsis-related organ failure assessment (SOFA) score at admission and after 1 hour of NIV, higher heart rate, lower PaO 2 /FIO 2 and bicarbonate (2) .
The debate concerning the use of NIV for treatment of severe CAP increased during H1N1 pandemic. Initially, NIV was felt to be contraindicated because of a hypothetical risk of spreading the infection. This hypothesis was refuted by Simmonds et.al. who found that TANAFFOS Nicolini A, et al. 21 Tanaffos 2014; 13 (4) : [20] [21] [22] [23] [24] [25] [26] [27] [28] the droplets generated during NIV are > 10 µm; these are unlikely to be airborne (6) .
Over time, NIV success increased (7, 8) . The success rate was as high as 76% with avoidance of intubation and fewer associated infection complications ( e.g., sepsis, septic shock and/or catheter-related infections (6) .
However, despite good outcomes in H1N1 patients and more recent randomized studies on the use of helmet continuous positive airway pressure (CPAP) versus oxygen therapy in severe hypoxemic respiratory failure due to pneumonia, in which the technique reduced the intubation rate (9, 10) , the efficacy of NIV in pneumonia has not been definitively established (11) . Predictors of NIV failure have not been well defined (12) . From our long experience with NIV, we learned that appropriate patient selection is the key to success (13) .
The aim of this study was to evaluate the efficacy of NIV and factors related to its failure and mortality in patients with CAP and severe acute respiratory failure (ARF).
MATERIALS AND METHODS
We retrospectively followed 130 consecutive patients with severe ARF due to CAP defined as the ratio of arterial oxygen tension to inspired oxygen fraction 
Primary outcomes:
NIV failure and hospital mortality were the primary outcomes.
Secondary outcomes:
Changes in arterial blood gases (ABG) analysis at admission and after 1 hour of NIV, NIV duration and the length of hospital stay were the secondary outcomes.
Statistical analysis:
Continuous variables expressed as mean ± standard deviation were compared with the regression analysis corrected for age. Categorical variables expressed as number and percentages were compared using chi-square 
RESULTS
One hundred and thirty patients admitted with CAP received NIV (76 males and 54 females aged 59.74±16.17 years) for 90±96 hours, i.e., 3.7±3.3 days (mean ± SD).
During NIV treatment, the pressure support ventilation (PSV) was 11±5 cm H2O and PEEP was 8±4 cmH2O. NIV was successfully used in 104 patients (80.0 %). Twenty-six patients experienced NIV failure; 18 were intubated and admitted to ICU. Eight other patients had previously stated that they did not want to be intubated and died. The main reasons for intubation were worsening of respiratory insufficiency (10 patients), cardio-respiratory arrest (four patients), and multi-organ failure (four patients).
Eight patients who were not intubated died because of multi-organ failure (three patients) and worsening of respiratory failure (five patients).
Acute respiratory failure de novo:
Acute respiratory failure de novo was considered as a separate entity (2) Patients in the ARF group did not have significant differences at admission and showed only a drop in respiratory rate and heart rate after 1 hour of NIV in patients with NIV success. In those who failed NIV there was a significant increase of A-aDO 2 after 24 hours in patients (P≤0.02) ( Table 2 ). In multivariate analysis of predictors associated with NIV failure in the two groups, a higher heart rate after 1 hour, a higher A-aDO2 after 24 hours, and a higher X-ray score Opravil score) at admission predicted failure (Table 3) .
Survival:
Hospital survivors had less pulmonary involvement as assessed by X ray (Opravil) score, a lower LDH at admission, a greater improvement of respiratory and heart rate after 24 hours of NIV and a better PaO 2 /FiO 2 and AaDO 2 after 24 hours compared with those who died.
In patients with de novo ARF survival was also related to A- (Table 4) . In total population, the multivariate analysis identified a higher LDH at admission, a higher X-ray score (Opravil) at admission, higher heart rate after 24 hours and higher A-aDO 2 after 24 hours as independent predictors of hospitality mortality (Table 5 ). Figure 1 shows the predictors of hospital mortality using ROC curves. The criteria for intubation were not standardized "a priori" but followed our institutional guidelines. This reflects the "real life"scenario of the study.
CONCLUSIONS
In conclusion, in this observational study, successful treatment was strongly related to less pulmonary involvement and to a prompt and continued response to medical and NIV treatment. Continuous and strict monitoring in an appropriate environment is of paramount importance.
